Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas

Hypertension

Volumn 63, Issue 1, 2014, Pages 188-195

  Williams, Tracy Ann ^a   Monticone, Silvia ^a   Schack, Vivien R ^b   Stindl, Julia ^c   Burrello, Jacopo ^a   Buffolo, Fabrizio ^a   Annaratone, Laura ^a   Castellano, Isabella ^a   Beuschlein, Felix ^d   Reincke, Martin ^d   Lucatello, Barbara ^a   Ronconi, Vanessa ^e   Fallo, Francesco ^f   Bernini, Giampaolo ^g   Maccario, Mauro ^a   Giacchetti, Gilberta ^e   Veglio, Franco ^a   Warth, Richard ^c   Vilsen, Bente ^b   Mulatero, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e OSPEDALI RIUNITI   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF PISA   (Italy)

Author keywords

Adrenal glands; Aldosterone; Conn adenoma; Hypertension; Potassium channels; Sodium potassium exchanging ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE SYNTHASE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL 4; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNJ5; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 2B3; UNCLASSIFIED DRUG;

ADRENAL CELL; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SOMATIC MUTATION; UPREGULATION; WHOLE CELL;

ADRENAL GLANDS; ALDOSTERONE; CONN ADENOMA; HYPERTENSION; POTASSIUM CHANNELS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; ALDOSTERONE SYNTHASE; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENE EXPRESSION; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; MUTATION; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84891628322     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01733     Document Type: Article

References (27)

1. Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA. Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol. 2013;9:104-112
2. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772
3. Boulkroun S, Beuschlein F, Rossi GP, et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension. 2012;59:592-598
4. Monticone S, Hattangady NG, Nishimoto K, et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab. 2012;97:E1567-E1572
5. Åkerström T, Crona J, Delgado Verdugo A, et al. Comprehensive resequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One. 2012;7:e41926
6. Mulatero P, Tauber P, Zennaro MC, et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension. 2012;59:235-240
7. Murthy M, Azizan EA, Brown MJ, O'Shaughnessy KM. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma. J Hypertens. 2012;30:1827-1833
8. Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology. 2012;153:1774-1782
9. Williams TA, Monticone S, Crudo V, Warth R, Veglio F, Mulatero P. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension. 2012;59:833-839
10. Boulkroun S, Golib Dzib JF, Samson-Couterie B, Rosa FL, Rickard AJ, Meatchi T, Amar L, Benecke A, Zennaro MC. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling. Mol Cell Endocrinol. 2013;371:221-227
11. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45:440-444, 444e1
12. Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C, Giraudo G, Passarino G, Garabello D, Verhovez A, Rabbia F, Veglio F. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008;93:1366-1371
13. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281
14. Williams TA, Monticone S, Morello F, Liew CC, Mengozzi G, Pilon C, Asioli S, Sapino A, Veglio F, Mulatero P. Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension. 2010;55:1468-1475
15. Fink M, Lesage F, Duprat F, Heurteaux C, Reyes R, Fosset M, Lazdunski M. A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J. 1998;17:3297-3308
16. Newcombe RG. Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat Med. 1998;17:857-872
17. Einholm AP, Toustrup-Jensen M, Andersen JP, Vilsen B. Mutation of Gly-94 in transmembrane segment M1 of Na+,K+-ATPase interferes with Na+ and K+ binding in E2P conformation. Proc Natl Acad Sci U S A. 2005;102:11254-11259
18. Nogueira EF, Xing Y, Morris CA, Rainey WE. Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol. 2009;42:319-330
19. Azizan EA, Lam BY, Newhouse SJ, Zhou J, Kuc RE, Clarke J, Happerfield L, Marker A, Hoffman GJ, Brown MJ. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa-and zona fasciculatalike tumors. J Clin Endocrinol Metab. 2012;97:E819-E829
20. Taguchi R, Yamada M, Nakajima Y, Satoh T, Hashimoto K, Shibusawa N, Ozawa A, Okada S, Rokutanda N, Takata D, Koibuchi Y, Horiguchi J, Oyama T, Takeyoshi I, Mori M. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab. 2012;97:1311-1319
21. Kaplan JH. Biochemistry of Na,K-ATPase. Annu Rev Biochem. 2002;71:511-535
22. Morth JP, Pedersen BP, Toustrup-Jensen MS, Sørensen TL, Petersen J, Andersen JP, Vilsen B, Nissen P. Crystal structure of the sodium-potassium pump. Nature. 2007;450:1043-1049
23. Einholm AP, Andersen JP, Vilsen B. Importance of Leu99 in transmembrane segment M1 of the Na+, K+ -ATPase in the binding and occlusion of K+. J Biol Chem. 2007;282:23854-23866
24. Hajnóczky G, Csordás G, Hunyady L, Kalapos MP, Balla T, Enyedi P, Spät A. Angiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: Possible contribution to stimulation of aldosterone production. Endocrinology. 1992;130:1637-1644
25. Yingst DR, Davis J, Krenz S, Schiebinger RJ. Insights into the mechanism by which inhibition of Na,K-ATPase stimulates aldosterone production. Metabolism. 1999;48:1167-1171
26. Spät A. Glomerulosa cell-a unique sensor of extracellular K+ concentration. Mol Cell Endocrinol. 2004;217:23-26
27. Bandulik S, Penton D, Barhanin J, Warth R. TASK1 and TASK3 potassium channels: Determinants of aldosterone secretion and adrenocortical zonation. Horm Metab Res. 2010;42:450-457